#1Rx icon

ZEPZELCA is the #1-PRESCRIBED medication in the second-line treatment of SCLC following first-line platinum-based therapies with over 20,000 adult patients treated to date in the United States.2,3

Total number of patients treated is determined as total vials sold divided by 7.5 (average vials per patient) based on SHS claims data from July 2020–December 2023.

Source: Symphony Health Solutions claims data: July 2020–December 2023.